Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004)

ClinicalTrials.gov ID: NCT03285490

Public ClinicalTrials.gov record NCT03285490. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 9:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Double-Blind, Vehicle-Controlled, Randomized, Parallel Group, Multicenter, Efficacy and Safety Study of KX2-391 Ointment 1% in Adult Subjects With Actinic Keratosis on the Face or Scalp

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This Phase III study was designed to evaluate the efficacy and safety of KX2-391 Ointment 1% in adult participants when applied to an area of skin containing 4-8 stable, clinically typical actinic keratosis (AK) lesions on the face or scalp.

Study identification

NCT ID
NCT03285490
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Almirall, S.A.
Industry
Enrollment
351 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 15, 2017 (Actual)
Primary completion
May 7, 2018 (Actual)
Completion
Apr 24, 2019 (Actual)
Last update posted
Mar 10, 2021

2017 – 2019

United States locations

U.S. sites
30
U.S. states
20
U.S. cities
30
Facility City State ZIP Site status
Alliance Dermatology Phoenix Arizona 85032 —
Synexus US Tucson Arizona 85712 —
Burke Pharmaceutical Research Hot Springs Arkansas 71913 —
Dermatology Specialists, Inc. Murrieta California 92562 —
Dermatology Specialists, Inc. Oceanside California 92056 —
Skin Surgery Medical Group, Inc. San Diego California 92117 —
Synexus Santa Rosa California 95405 —
AboutSkin Dermatology Greenwood Village Colorado 80111 —
Study Protocol, Inc Boynton Beach Florida 33437 —
Sweet Hope Research Specialty, Inc. Miami Lakes Florida 33016 —
Forward Clinical Trials, Inc. Tampa Florida 33624 —
Laser & Skin Surgery Center of Indiana Carmel Indiana 46032 —
Dawes Fretzin Clinical Research Group Indianapolis Indiana 46256 —
DS Research Louisville Kentucky 40241 —
Clinical Trials of SWLA, LLC Lake Charles Louisiana 70601 —
Hamzavi Dermatology Fort Gratiot Michigan 48059 —
Medisearch Clinical Trials Saint Joseph Missouri 64506 —
Henderson Dermatology Research Henderson Nevada 89052 —
Activmed Practices & Research, Inc Portsmouth New Hampshire 03801 —
Union Square Laser Dermatology New York New York 10003 —
Aventiv Research Inc. Dublin Ohio 43016 —
Oregon Medical Research Center Portland Oregon 97223 —
Clinical Research Center of the Carolinas Charleston South Carolina 29407 —
Dermatology Associates Of Knoxville, PC Knoxville Tennessee 37917 —
Rivergate Dermatology Clinical Research Springfield Tennessee 37072 —
DermResearch Austin Texas 78759 —
Suzanne Bruce and Associates, P.A., The Center for Skin Research Houston Texas 77056 —
Clinical Trials of Texas, Inc. San Antonio Texas 78229 —
The Education & Research Foundation, Inc. Lynchburg Virginia 24501 —
Dermatology Associates of Seattle Seattle Washington 98101 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03285490, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 10, 2021 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03285490 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →